Understanding your priorities helps your doctor develop an individualized treatment plan that addresses your most pressing health concerns
Individual response to GLP-1 medications varies meaningfully variants in GLP1R (the GLP-1 receptor itself), GIPR (which matters specifically for tirzepatide's dual-agonist mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with different weight-loss curves and different tolerability profiles
Consistency: Do not skip doses
Studies on animal models have shown that Ipamorelin stimulates the secretion of growth hormone (GH) from somatotropic pituitary cells in a selective manner without the accompanying significant increase in cortisol, aldosterone or prolactin concentrations, which is observed with the administration of other GHRPs, such as GHRP-6 or GHRP-2
ALC is an important factor expanding the brains sources of energy
In the brain, GLP-1 works to make us feel full (technically called 'to increase satiety')